
News|Articles|June 1, 2006
Tiotropium use in patients with COPD exacerbation improves airflow limitation and decreases health resource utilization
Tiotropium use in patients with chronic obstructive pulmonary disease (COPD) exacerbation led to decreased health resource utilization (HRU) and improved airflow limitation, according to a randomized, double-blind, multicenter, parallel group study published in the European Respiratory Journal.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
3 insights from the third set of drugs for Medicare price negotiations
2
Don’t let ‘sleepmaxxing’ keep you up at night: Results from the 2025 American Academy of Sleep Medicine survey on sleep tracking
3
What UnitedHealth Group’s earnings call reveals about managed care trends
4
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
5




























